EGFR-IN-50
EGFR-IN-50 (Compound 9h) is a potent EGFR inhibitor against L858R resistance mutation (TEL-EGFR-L858R-BaF3: GI50=8 nM, TEL-EGFR-T790M-L858R-BaF3: GI50=6.03 μM) . EGFR-IN-50 shows anti-proliferative activity to cancer cells[1].
Product Specifications
CAS Number
2044508-48-5
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-50.html
Solubility
10 mM in DMSO
Smiles
C=CCSSCCC(OCCCOC1=CC2=C(C(NC3=CC(Br)=CC=C3)=NC=N2)C=C1OC)=O
Molecular Formula
C24H26BrN3O4S2
Molecular Weight
564.51
References & Citations
[1]You-Guang Zheng, et al. Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (H2S) donors as potent EGFR inhibitors against L858R resistance mutation. Eur J Med Chem. 2020 Sep 15;202:112522.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681576-500 1x 500 µL
Cytokeratin, Basic (Type II or HMW) (Epithelial Marker) (KRTH/1576R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY419315 100 µg
IF 2(Mt) (MTIF2) (NM_002453) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC942752-100 1x 100 µL
Heregulin-1 / Neuregulin-1 (Breast and Urothelial Marker) (NRG1/2752), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 